Therapeutic Eye Health™
Daily antioxidant support for healthier eyes
Therapeutic Eye Health™ is a patented topical antioxidant formulation developed to support ocular wellness by reducing oxidative stress, inflammation, and tear film disruption.
Overview
At a glance
Topical Care
Antioxidant-rich eye gel for daily ocular support.
Pet Market
Commercialized for companion animals as Optixcare® Eye Health.
Pet Market
Commercialized for companion animals as Optixcare® Eye Health.
Revenue Now
Licensed product already generating royalty revenue.
Revenue Now
Licensed product already generating royalty revenue.
Human Path
Planned expansion into the human dry eye market.
Human Path
Planned expansion into the human dry eye market.
Science
How it works
The formula combines natural antioxidants that help neutralize free radicals, reduce inflammation, and support a healthier ocular surface in the face of aging and environmental stress.
Helps reduce oxidative stress in the eye
Supports normal tear flow and comfort
Helps calm inflammation on the ocular surface
Patented formulation includes Astaxanthin, Resveratrol, Ethyl Pyruvate, and EGCG
Designed for daily wellness support
Benefits
What it helps support
Antioxidant Defense
Helps protect the eye from oxidative damage caused by age and environment.
Antioxidant Defense
Helps protect the eye from oxidative damage caused by age and environment.
Tear Support
Helps preserve tear flow and support ocular surface comfort.
Tear Support
Helps preserve tear flow and support ocular surface comfort.
Visual Health
Supports protection against cataract, retinal, and dry eye-related stress.
Visual Health
Supports protection against cataract, retinal, and dry eye-related stress.
Status
Commercial traction and future expansion
This product already has veterinary market presence and a defined route toward broader human use.
Patented topical antioxidant formulation
Currently licensed to Aventix Animal Health
Marketed as Optixcare™ Eye Health
FDA-sanctioned OTC veterinary device position
Currently generating royalty revenue
Human dry eye launch planned pending funding
Want to learn more about our products?
Contact us to learn more about our ophthalmic and neuroprotective product portfolio.
Want to learn more about our products?
Contact us to learn more about our ophthalmic and neuroprotective product portfolio.
Want to learn more about our products?
Contact us to learn more about our ophthalmic and neuroprotective product portfolio.